September 27, 2024
@
12:00 pm
–
1:00 pm
Register for this free teams webinar here:
https://futurebloodtesting.org/event/2024-09-27
Abstract: In this talk, Dr Stephen Lindsay will delve into the fundamental principles of participatory design, focusing on its role in democratizing the development of healthcare technologies. He will begin by exploring the core definition of participatory design, emphasizing its potential to empower users by involving them directly in the creation process. He will then contrast this approach with current Patient and Public Involvement and Engagement (PPIE) practices in the UK, highlighting how participatory design extends beyond consultation to share decision-making in design. The talk will also examine the specific challenges of applying participatory design in healthcare, navigating ethical considerations, ensuring inclusivity, and managing the complexities of working with vulnerable populations. Through case studies from his own work, he will demonstrate how participatory design can overcome these challenges, leading to more inclusive, effective, and ethically sound healthcare solutions, and offering a critical perspective on the limitations of traditional PPIE approaches.
Bio: Dr Stephen Lindsay is a Lecturer in Digital Healthcare and HCI at Glasgow University. His research is cantered on participatory design, particularly with marginalized groups such as older adults, people living with dementia, and individuals with brain injuries. Dr Lindsay believes that involving these under-heard voices in healthcare technology design not only fosters more ethical practices but also drives innovation. His work has addressed diverse areas, including designing digital tools for older adults, supporting less-literate diabetes patients in rural Pakistan, and creating technologies that genuinely reflect patients’ needs and experiences. Through this approach, Dr Lindsay contributes to the development of digital health tools that are both ethically sound and practically effective, grounded in the lived experiences of those they aim to serve.
This webinar is part of the 2024 Future Blood Testing Network+ webinar series. This series will feature a diverse range of speakers who are working in the areas of future blood testing and diagnostics.
The Engineering and Physical Sciences Research Council (EPSRC), in collaboration with the National Institute for Health and Care Research (NIHR), is calling for applications to develop a NetworkPlus focused on the use and development of novel tools and technologies that help people with dementia live independently.
This initiative is designed to support NetworkPlus grants that develop technologies to help people transform their care and health to become more independent at home. Networks should explore and identify the pathways and barriers to implementing these tools and technologies within the health and care system. They should also examine how technologies can be integrated into the home and coordinate care with carers and health and social care professionals, where appropriate
The role of the NetworkPlus is to nurture research ideas among its members and facilitate the transfer of knowledge to a broader community. Networks are encouraged to collaborate with a range of project partners.
🔗 To apply for this funding opportunity, visit: Technologies to enable independence for people living with dementia – UKRI
Key Dates:
- Publication Date: 25 April 2024
- Opening Date: 16 May 2024, 9:00am UK time
- Closing Date: 10 September 2024, 4:00pm UK time
Eligibility and Funding Details:
- Must be based at a UK research organisation eligible for EPSRC funding.
- The full economic cost (FEC) of projects can be up to £2,000,000.
- EPSRC and NIHR will fund 80% of the FEC.
- Project duration: Up to 36 months.
To be successful, proposals need to demonstrate a clear vision, an understanding of the wider context, and the added value arising from the network. Networks should set their research focus within the UK health and social care system, with a particular interest in how tools and technologies could be realistically implemented into the current system.
Don’t miss out on this opportunity!
Apply by 10 September 2024, 4:00pm UK time.
May 17, 2024
@
12:00 pm
–
1:00 pm
Register for this free teams webinar here:
https://futurebloodtesting.org/event/2024-05-17
Abstract: Although the need for better diagnostics, especially point-of-care testing, is clear, the uptake of novel technology lags a long way behind demonstration and research papers. Using several case studies from my own research, alongside insight from current state-of-the art notably in diagnostics for microbiology and infection, I will outline the technological basis for bioassay miniaturisation (i.e. tiny blood tests) and discuss the diagnostics innovation pathway. Examples will include a review of >10 years developing microfluidic quantitative multiplex immunoassays that can measure multiple biomarkers in blood, as well as our latest developments in measuring platelet cell function directly in blood.
Bio: With a background in fundamental immunology combined with expertise in biochemical engineering, Al Edwards is an interdisciplinary researcher focussed on solving current and future healthcare challenges using an engineering science approach that combines a range of fields from biology, biochemistry, chemistry and physics. He works at the interface between academic technology discovery and industrial development and have experience of both fundamental research and the commercialisation of new technology.
The two main challenges he currently work on are the development of affordable microfluidic technology for clinical diagnostics and microbiology, and the engineering science of complex biologic therapeutics such as vaccines.
This webinar is part of the Future Blood Testing Network+ Webinar Series. This series will feature a diverse range of speakers who are working in the areas of future blood testing and diagnostics.
